Calidi Biotherapeutics Inc (CLDI)

AMEX

$0.12

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. The company is headquartered in San Diego, California.

Website: https://www.calidibio.com

Sector:

Healthcare

Industry:

Biotechnology

Target: $120 (+103706.23%)

Market Cap

$1.99M

P/B Ratio

0.66

Beta (5Y)

1.70

Price Chart

Adjust inflation

Log

Valuation

Market Cap$1.99M

P/S50.83

P/B0.66

Profitability

Gross Profit (TTM)$31K

EBITDA-$18M

EPS-$3.64

Financial Health

Debt-to-Equity12.6%

Growth & Risk

Beta (5Y)1.70

Sharpe Ratio-3.08